VivoSim Labs, Inc. Depreciation
VivoSim Labs, Inc. (VIVS) reported Depreciation of $200.00 thousand for the 12-month period ending 2026-03-31, per its 10-K filed 2026-07-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:Depreciation · last filed 2026-07-14
- VivoSim Labs, Inc. depreciation for the quarter ending 2013-03-31 was $78.00K, a 420.00% increase year-over-year.
- VivoSim Labs, Inc. depreciation for the quarter ending 2012-03-31 was $15.00K.
- VivoSim Labs, Inc. depreciation for fiscal 2026 was $200.00K, a 33.33% decline from fiscal 2025.
- VivoSim Labs, Inc. depreciation for fiscal 2025 was $300.00K, a 0.00% change from fiscal 2024.
- VivoSim Labs, Inc. depreciation for fiscal 2024 was $300.00K, a 149999900.00% increase from fiscal 2023.
- VivoSim Labs, Inc. depreciation for fiscal 2023 was $0.20, a 100.00% decline from fiscal 2022.
| Period end | Depreciation 3 month | Depreciation 12 month | Depreciation 12 month as first filed | Depreciation 68 month | Depreciation 71 month | Depreciation 83 month |
|---|---|---|---|---|---|---|
| 2026-03-31 | $200.00K 10-K · filed 2026-07-14 | |||||
| 2025-03-31 | $300.00K 10-K · filed 2026-07-14 | |||||
| 2024-03-31 | $300.00K 10-K · filed 2025-06-05 | $0.30 10-K · filed 2024-05-31 | ||||
| 2023-03-31 | $0.20 10-K · filed 2024-05-31 | $211.00K 10-K · filed 2023-07-14 | ||||
| 2022-03-31 | $128.00K 10-K · filed 2023-07-14 | |||||
| 2021-03-31 | $27.00K 10-K · filed 2022-06-10 | |||||
| 2020-03-31 | $1.13M 10-K · filed 2021-06-15 | |||||
| 2019-03-31 | $969.00K 10-K · filed 2020-05-28 | |||||
| 2018-03-31 | $1.25M 10-K · filed 2019-06-03 | |||||
| 2017-03-31 | $1.14M 10-K · filed 2018-05-31 | |||||
| 2016-03-31 | $805.00K 10-K · filed 2018-05-31 | |||||
| 2015-03-31 | $464.00K 10-K · filed 2017-06-07 | |||||
| 2014-03-31 | $380.00K 10-K · filed 2016-06-09 | $794.00K 10-K · filed 2014-06-10 | ||||
| 2013-03-31 | $78.00K 10-K · filed 2015-06-09 | $414.00K 10-KT · filed 2013-05-24 | ||||
| 2012-12-31 | $188.00K 10-K · filed 2015-06-09 | $336.00K 10-K · filed 2013-03-15 | ||||
| 2012-03-31 | $15.00K 10-K · filed 2015-06-09 | |||||
| 2011-12-31 | $63.00K 10-K · filed 2014-06-10 | |||||
| 2010-12-31 | $57.00K 10-KT · filed 2013-05-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |